Personalized Chemotherapy

Personalized Chemotherapy is a chemotherapy regimen strategy that tailors treatment protocols to individual patient characteristics, such as genetic profiles, tumor biomarkers, and pharmacogenomic data, to optimize therapeutic efficacy and minimize adverse effects in the context of bone sarcoma and hematologic malignancies.

79

Publications

3.4K

Citations

662

Authors

292

Institutions

Publications per year

2017–2026

35

Authors

662

  1. HL
    Howard L. McLeod

    Washington University in St. Louis, United States

    2 publications · 100 citations

    2

    h-index

  2. CA
    Carol Aghajanian

    Memorial Sloan Kettering Cancer Center, United States

    2 publications · 102 citations

    2

    h-index

  3. GB
    Gerold Bepler

    Moffitt Cancer Center, United States

    2 publications · 53 citations

    2

    h-index

  4. LH
    Li Hua

    Shandong University, China

    2 publications · 40 citations

    2

    h-index

  5. MH
    Manuel Hidalgo

    Johns Hopkins University, United States

    2 publications · 54 citations

    2

    h-index

1–5 of 662

Venues

  1. Journal of Clinical Oncology

    6 publications · 462 citations

    6

    h-index

  2. PLoS ONE

    4 publications · 161 citations

    4

    h-index

  3. Translational Oncology

    3 publications · 39 citations

    3

    h-index

  4. Clinical Cancer Research

    3 publications · 268 citations

    3

    h-index

  5. Clinical Colorectal Cancer

    2 publications · 54 citations

    2

    h-index

1–5